Biotech

Latest Articles

Rivus articles information to support muscle-sparing being overweight drug claims

.Rivus Pharmaceuticals has introduced the information responsible for its phase 2 being overweight g...

BMS pays $110M to create T-cell treatment deal, helping Top purchase time to improve prioritized pipeline

.Bristol Myers Squibb is actually paying for Prime Medicine $110 million upfront to create reagents ...

Generate gains an additional $1B-plus Significant Pharma partnership

.Novartis has actually inked a package potentially worth more than $1 billion along with Flagship-fo...

Metsera GLP-1 information slice reveals 7.5% fat loss at 36 times

.Just recently debuted Metsera is unfolding some stage 1 record for its own GLP-1 receptor agonist, ...

Flagship wishes biotechs group to Mirai to boost genetic medications

.In the middle of the hereditary medicines arms ethnicity, Crown jewel Pioneering is introducing a b...

BioAge eyes $180M from IPO, personal placement for excessive weight trials

.BioAge Labs is considering all around $180 thousand in preliminary proceeds from an IPO and also an...

Merck's LAG-3 combo neglects colorectal cancer cells period 3 study

.A try by Merck &amp Co. to open the microsatellite stable (MSS) metastatic intestines cancer cells ...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Partners has actually finalized a fund of 180 thousand euros ($ 200 million), fu...

BioAge produces $198M from IPO as obesity biotech joins Nasdaq

.BioAge Labs is actually generating nearly $200 thousand through its own Nasdaq IPO today, along wit...

Acadia delivers BMS vet on board as chief executive officer-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, firings an...

Cassava pays $40M over allegedly confusing Alzheimer's upgrade

.Cassava Sciences has agreed to pay out $40 thousand to solve an examination in to claims it made de...

Merck bags alternatives on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has actually gotten choices on 2 Evaxion Biotech vaccination prospects, paying $3.2 ...

Enanta's RSV antiviral crushes virus-like load in problem research

.Enanta Pharmaceuticals has linked its own breathing syncytial infection (RSV) antiviral to substant...

Biogen cans SAGE-324 partnership after vital shake fall short

.Biogen has provided the final rites to its cooperation along with Sage Therapeutics on SAGE-324, br...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion credit ratings

.On the exact same time that some Parkinson's ailment drugs are actually being disputed, AbbVie has ...

Arch closes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Endeavor Allies is s...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has actually snooped potential in Aitia's "electronic identical twin" special...

Windtree's surprise med brings up blood pressure in latest phase 2 succeed

.While Windtree Therapies has strained to increase the monetary origins needed to have to endure, a ...

2 cancer cells biotechs combine, producing worldwide footprint

.OncoC4 is taking AcroImmune-- and its own internal medical manufacturing abilities-- under its wing...

Amgen reports first phase 3 gain for $400M dermatitis drug

.Amgen has actually shared (PDF) the first phase 3 information on its own $400 thousand dermatitis m...